Yes, as soccertese said, it's going to be a very expensive version of Amantadine. This will be a once-a-day (taken before bedtime) extended release version. It will cut down the number of pills taken. It is supposed to also reduce some of the Amantadine side side effects. However, the trials never tested Gocovri against regular Amantadine. It was only tested vs Placebo. So, we really don't know for sure if it has fewer side effects. It will be highly priced, so, unless insurance covers a good percentage of the cost, it's hard to see why I would switch from regular Amantadine to the new ER version.

One side note, many people may not realize that amantadine has never been FDA approved for use in PD. All of us who take it are doing so off-label. So, at least this now puts an official approval to the drug for use in PD.